CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,298,000 | -25.6% | 180,645 | -18.2% | 0.00% | -25.0% |
| Q4 2020 | $5,779,000 | +44.4% | 220,922 | -3.9% | 0.00% | 0.0% |
| Q3 2020 | $4,001,000 | +10.7% | 229,883 | +7.0% | 0.00% | 0.0% |
| Q2 2020 | $3,615,000 | +42.6% | 214,944 | +0.8% | 0.00% | +33.3% |
| Q1 2020 | $2,535,000 | -44.2% | 213,196 | -43.2% | 0.00% | -25.0% |
| Q4 2019 | $4,544,000 | +58.5% | 375,571 | +85.2% | 0.00% | +33.3% |
| Q3 2019 | $2,866,000 | +108.9% | 202,741 | +64.8% | 0.00% | +50.0% |
| Q2 2019 | $1,372,000 | -5.6% | 123,037 | -0.6% | 0.00% | 0.0% |
| Q1 2019 | $1,454,000 | -18.6% | 123,837 | -7.4% | 0.00% | -33.3% |
| Q4 2018 | $1,786,000 | -15.0% | 133,695 | -10.8% | 0.00% | 0.0% |
| Q3 2018 | $2,102,000 | -14.8% | 149,908 | -4.5% | 0.00% | 0.0% |
| Q2 2018 | $2,467,000 | +6.1% | 156,958 | +11.0% | 0.00% | 0.0% |
| Q1 2018 | $2,326,000 | -21.7% | 141,417 | -14.1% | 0.00% | -25.0% |
| Q4 2017 | $2,972,000 | -5.2% | 164,557 | +1.3% | 0.00% | -20.0% |
| Q3 2017 | $3,135,000 | +79.2% | 162,459 | +9.6% | 0.01% | +66.7% |
| Q2 2017 | $1,749,000 | +11.6% | 148,200 | +3.6% | 0.00% | 0.0% |
| Q1 2017 | $1,567,000 | +36.1% | 143,000 | -9.8% | 0.00% | +50.0% |
| Q4 2016 | $1,151,000 | +28.7% | 158,600 | +15.3% | 0.00% | +100.0% |
| Q3 2016 | $894,000 | +20.6% | 137,500 | +1.3% | 0.00% | 0.0% |
| Q2 2016 | $741,000 | +13.1% | 135,700 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $655,000 | -11.5% | 140,000 | -5.7% | 0.00% | 0.0% |
| Q4 2015 | $740,000 | +32.6% | 148,500 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $558,000 | -56.6% | 148,500 | -30.6% | 0.00% | -50.0% |
| Q2 2015 | $1,286,000 | +194.3% | 214,000 | +39.4% | 0.00% | +100.0% |
| Q1 2015 | $437,000 | 0.0% | 153,500 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $437,000 | +6.3% | 153,500 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $411,000 | -4.4% | 153,500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $430,000 | -32.9% | 153,500 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $641,000 | +36.4% | 153,500 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $470,000 | +89.5% | 153,500 | -1.6% | 0.00% | – |
| Q3 2013 | $248,000 | +4.2% | 156,000 | +13.3% | 0.00% | – |
| Q2 2013 | $238,000 | – | 137,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |